Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$272,258
-$16,378 QoQ
Shares Held
66,243
+52.6% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Man Group plc holds $362,228,781 across 31 Drug Manufacturers - Specialty & Generic names. EOLS ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
783,624 | $92,632,192 | |
| 2 | VTRS |
Viatris Inc
|
4,092,860 | $55,294,537 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
415,909 | $54,791,850 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
77,495 | $45,952,984 | |
| 5 | ALKS |
Alkermes plc.
|
625,046 | $22,101,626 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
208,694 | $16,048,568 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,293,300 | $12,312,216 | |
| 8 | PRGO |
PERRIGO Co plc
|
986,046 | $10,590,134 |
All Filings in EOLS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $272,258 | 66,243 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $288,636 | 43,404 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $509,337 | 82,954 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,158,148 | 125,749 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,224,978 | 101,827 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $120,678 | 10,931 | Shares | Defined | 2025-02-14 | |
| 2023-06-30 | $392,005 | 53,921 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $790,417 | 93,430 | Principal | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||